EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Effect of Somatostatin Analogue (SMS 201-995) Administration on Portal Blood Flow in Patients with Liver Cirrhosis

S. KAPICIOĞLU ¹ , O. YEŞİLDAĞ ² , E. OVALI ² , A.H. BAKİ ¹ , N. KAYA ¹

Author Affiliation(s)

1.

Ondokuz May. Uni. school ofMedkine, Departrnent of Medicine, Section of Gastroenterology and Cardiology, Sarnsun-TURKEY

2.

Ondokuz May. Uni. School of Medicine, Department of Medicine, Section of Gastroenterology and Cardiology, Samsun-TURKEY

Turk J Gastroenterol 1992; 3: 469-473

Keywords : Sormatostatin analogue, portal flow, portal velocity, livercirrhosis

Read: 783 Downloads: 640 Published: 26 April 2020

Volume 3, Issue 3, July 1992

Previous Article

Files